James L. Freddo serves as Executive at ANADYS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, James L. Freddo has executed 6 insider transactions totaling $38.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 8, 2018 involved selling 3,000 shares valued at $81.0K.
James L. Freddo currently holds 3,000 shares of ANADYS PHARMACEUTICALS INC (ANDS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James L. Freddo has been a net buyer of ANDS stock. They have purchased $38.4K and sold $0 worth of shares.
James L. Freddo's most recent insider trade was on Feb 8, 2018, when they sold 3,000 shares at $27.00 per share.
Get notified when new Form 4 filings are submitted
| $5.39 |
| Discretionary |
| Dec 3, 2010 | INHI.OB | $0 | Award | 75,000 | $N/A | Discretionary |
| Jun 3, 2008 | INHI.OB | $0 | Award | 40,000 | $N/A | Discretionary |
| Aug 15, 2007 | ANDS | $11.3K | Purchase | 5,000 | $2.25 | Discretionary |
| Aug 15, 2007 | ANDS | $11.0K | Purchase | 5,000 | $2.20 | Discretionary |